Characteristics of Patients That Do Not Initially Respond to Intravenous Antihypertensives in the Emergency Department: Subanalysis of the CLUE Trial

Introduction: Hypertensive emergency has a high mortality risk and the treatment goal is to quickly lower blood pressure with intravenous (IV) medications. Characteristics that are associated with non-response to IV antihypertensives have not been identified. The objective is to identify patient cha...

Full description

Bibliographic Details
Main Authors: Freiermuth, Caroline E., Chandra, Abhinav, Peacock, W. Frank
Format: Article
Language:English
Published: eScholarship Publishing, University of California 2015-03-01
Series:Western Journal of Emergency Medicine
Subjects:
Online Access:http://escholarship.org/uc/item/5cf8j5p2
id doaj-58699e23bad941489a6d1d5b840fe0c9
record_format Article
spelling doaj-58699e23bad941489a6d1d5b840fe0c92020-11-24T23:15:00ZengeScholarship Publishing, University of CaliforniaWestern Journal of Emergency Medicine1936-900X1936-90182015-03-0116227628310.5811/westjem.2015.1.23308Characteristics of Patients That Do Not Initially Respond to Intravenous Antihypertensives in the Emergency Department: Subanalysis of the CLUE TrialFreiermuth, Caroline E.0Chandra, Abhinav1Peacock, W. Frank2Duke University Medical Center, Division of Emergency Medicine Durham, North CarolinaKaiser Permanente, South Sacramento, Sacramento, CaliforniaBaylor College of Medicine, Department of Emergency Medicine, Houston, TexasIntroduction: Hypertensive emergency has a high mortality risk and the treatment goal is to quickly lower blood pressure with intravenous (IV) medications. Characteristics that are associated with non-response to IV antihypertensives have not been identified. The objective is to identify patient characteristics associated with resistance to IV antihypertensives. Methods: This was a subanalysis of patients enrolled in the previously described comparative effectiveness trial of IV nicardipine vs. labetalol use in the emergency department (CLUE) study, a randomized trial of nicardipine vs. labetalol. Non-responders were defined as those patients who did not achieve target systolic blood pressure (SBP), as set by the treating physician, within thirty minutes of IV antihypertensive medication, +/- 20mmHg. Stepwise logistic regression was used to identify covariates associated with the measurement outcomes. Results: CLUE enrolled 226 patients, 52.7% female, 76.4% black, mean age of 52.6±14.6 years, of whom 110 were treated with nicardipine and 116 with labetalol. The median (IQR) initial systolic blood pressure was 211mmHg (198, 226), 210 (200, 230), and 211mmHg (198, 226), for the total, non-responder, and responder cohorts, respectively (p-value=0.65, 95% CI [-5.8-11.3]). Twenty-nine were non-responders, 9 in the nicardipine and 20 in the labetalol group. In univariate analysis, several symptoms suggestive of end organ damage were associated with non-response. After multiple variable logistic regression (AUC = 0.72), treatment with labetalol (OR 2.7, 95% CI [1.1-6.7]), history of stroke (OR 5.4, 95% CI [1.6-18.5]), and being male (OR 3.3, 95% CI [1.4-8.1]) were associated with failure to achieve target blood pressure. Conclusion: Male gender and history of previous stroke are associated with difficult to control blood pressure. [West J Emerg Med. 2015;16(2):276–283.]http://escholarship.org/uc/item/5cf8j5p2CLUE Trial
collection DOAJ
language English
format Article
sources DOAJ
author Freiermuth, Caroline E.
Chandra, Abhinav
Peacock, W. Frank
spellingShingle Freiermuth, Caroline E.
Chandra, Abhinav
Peacock, W. Frank
Characteristics of Patients That Do Not Initially Respond to Intravenous Antihypertensives in the Emergency Department: Subanalysis of the CLUE Trial
Western Journal of Emergency Medicine
CLUE Trial
author_facet Freiermuth, Caroline E.
Chandra, Abhinav
Peacock, W. Frank
author_sort Freiermuth, Caroline E.
title Characteristics of Patients That Do Not Initially Respond to Intravenous Antihypertensives in the Emergency Department: Subanalysis of the CLUE Trial
title_short Characteristics of Patients That Do Not Initially Respond to Intravenous Antihypertensives in the Emergency Department: Subanalysis of the CLUE Trial
title_full Characteristics of Patients That Do Not Initially Respond to Intravenous Antihypertensives in the Emergency Department: Subanalysis of the CLUE Trial
title_fullStr Characteristics of Patients That Do Not Initially Respond to Intravenous Antihypertensives in the Emergency Department: Subanalysis of the CLUE Trial
title_full_unstemmed Characteristics of Patients That Do Not Initially Respond to Intravenous Antihypertensives in the Emergency Department: Subanalysis of the CLUE Trial
title_sort characteristics of patients that do not initially respond to intravenous antihypertensives in the emergency department: subanalysis of the clue trial
publisher eScholarship Publishing, University of California
series Western Journal of Emergency Medicine
issn 1936-900X
1936-9018
publishDate 2015-03-01
description Introduction: Hypertensive emergency has a high mortality risk and the treatment goal is to quickly lower blood pressure with intravenous (IV) medications. Characteristics that are associated with non-response to IV antihypertensives have not been identified. The objective is to identify patient characteristics associated with resistance to IV antihypertensives. Methods: This was a subanalysis of patients enrolled in the previously described comparative effectiveness trial of IV nicardipine vs. labetalol use in the emergency department (CLUE) study, a randomized trial of nicardipine vs. labetalol. Non-responders were defined as those patients who did not achieve target systolic blood pressure (SBP), as set by the treating physician, within thirty minutes of IV antihypertensive medication, +/- 20mmHg. Stepwise logistic regression was used to identify covariates associated with the measurement outcomes. Results: CLUE enrolled 226 patients, 52.7% female, 76.4% black, mean age of 52.6±14.6 years, of whom 110 were treated with nicardipine and 116 with labetalol. The median (IQR) initial systolic blood pressure was 211mmHg (198, 226), 210 (200, 230), and 211mmHg (198, 226), for the total, non-responder, and responder cohorts, respectively (p-value=0.65, 95% CI [-5.8-11.3]). Twenty-nine were non-responders, 9 in the nicardipine and 20 in the labetalol group. In univariate analysis, several symptoms suggestive of end organ damage were associated with non-response. After multiple variable logistic regression (AUC = 0.72), treatment with labetalol (OR 2.7, 95% CI [1.1-6.7]), history of stroke (OR 5.4, 95% CI [1.6-18.5]), and being male (OR 3.3, 95% CI [1.4-8.1]) were associated with failure to achieve target blood pressure. Conclusion: Male gender and history of previous stroke are associated with difficult to control blood pressure. [West J Emerg Med. 2015;16(2):276–283.]
topic CLUE Trial
url http://escholarship.org/uc/item/5cf8j5p2
work_keys_str_mv AT freiermuthcarolinee characteristicsofpatientsthatdonotinitiallyrespondtointravenousantihypertensivesintheemergencydepartmentsubanalysisofthecluetrial
AT chandraabhinav characteristicsofpatientsthatdonotinitiallyrespondtointravenousantihypertensivesintheemergencydepartmentsubanalysisofthecluetrial
AT peacockwfrank characteristicsofpatientsthatdonotinitiallyrespondtointravenousantihypertensivesintheemergencydepartmentsubanalysisofthecluetrial
_version_ 1725592454569132032